Metrics
- Price
- $163.06
- Market Cap $M
- 21,622
- Rel Volume
- 0.69
- Vol Up 2W
- 55.60%
- Vol Trend 2W
- -31.10%
- 1D
- -0.82%
- 1W
- -3.24%
- 1M
- -0.07%
- 1M Slope
- +0.99%
- 6M Range
- 117.46%
- Score
- 70.6
- Sharp
- 5.4
Volume
Profile
Guardant Health develops blood-based diagnostic tests for cancer screening, therapy selection, and minimal residual disease monitoring using genomic analysis.
Diagnostics
Healthcare
Biotech